A detailed history of Cibc Asset Management Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 2,020 shares of LNTH stock, worth $184,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,020
Holding current value
$184,123
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$77.7 - $123.62 $156,954 - $249,712
2,020 New
2,020 $221,000
Q2 2022

Aug 09, 2022

SELL
$55.54 - $72.65 $11,830 - $15,474
-213 Reduced 3.97%
5,158 $341,000
Q1 2022

May 06, 2022

BUY
$24.28 - $56.64 $130,407 - $304,213
5,371 New
5,371 $297,000
Q4 2021

Feb 08, 2022

SELL
$22.54 - $30.44 $178,359 - $240,871
-7,913 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$24.23 - $28.59 $6,396 - $7,547
264 Added 3.45%
7,913 $203,000
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $149,231 - $211,418
7,649 New
7,649 $211,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.27B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.